<!DOCTYPE html>
<html manifest="manifest.manifest">
<head>
	<meta http-equiv=Content-Type content="text/html; charset=utf-8">
	<title>MRCG Clinical Guidelines</title>
	<meta name="viewport" content="width=device-width, initial-scale=1.0, minimum-scale=1.0, maximum-scale=2.0, user-scalable=1">
	<meta name=Generator content="Microsoft Word 14 (filtered)">
	<link rel="manifest" href="/manifest.json">	
<link rel="stylesheet" href="jquery.mobile-1.4.5.min.css" />
	<link rel="stylesheet" href="mystyle.css" />
	<script src="jquery-1.11.1.min.js"></script>
	<script src="jquery.mobile-1.4.5.min.js"></script>
	<script type="text/javascript" src="cordova.js"></script>
	<script>
	    		$(function(){
			$("[data-role='header'], [data-role='footer']").toolbar();
		});
  	  $(document).one('pagebeforecreate', function () {
	        $('input[data-type="search"]').val("");
	    	        $.get("panel.html", function (data2) {
            $.mobile.pageContainer.prepend(data2);
              $("[data-role=panel]").panel().enhanceWithin();
        }, "html");
	           $.get("header.html", function (data) {
      $.mobile.pageContainer.prepend(data);
      $("[data-role='header']").toolbar().enhanceWithin();
    }, "html");
    $.get("footer.html", function (data) {
      $.mobile.pageContainer.append(data);
      $("[data-role='footer']").toolbar().enhanceWithin();
    }, "html");
        $('.WordSection1').wrap('<div role="main" class="ui-content">');
        $('table').wrap('<div class="tableCont"></div>');
        $('img').wrap('<div class="tableCont"></div>');
        $.mobile.pageContainer.enhanceWithin();
	  });
	        $(document).bind( "pagechange", function( ) {
        $('table').wrap('<div class="tableCont"></div>');
        $('img').wrap('<div class="tableCont"></div>');
        $('.tableCont').enhanceWithin();
      } );
			// When the user scrolls down 20px from the top of the document, show the button
		window.onscroll = function() {scrollFunction()};
		function scrollFunction() {
		  if (document.body.scrollTop > 20 || document.documentElement.scrollTop > 20) {
			document.getElementById("myBtn").style.display = "block";
		  } else {
			document.getElementById("myBtn").style.display = "none";
		  }
		}
		// When the user clicks on the button, scroll to the top of the document
		function topFunction() {
		  document.body.scrollTop = 0; // For Safari
		  document.documentElement.scrollTop = 0; // For Chrome, Firefox, IE and Opera
		}</script>      



	








  

</head>
<body lang=EN-GB link=blue vlink=purple>

<div data-role="page">
	<div role="main" class="ui-content">
<div class=WordSection1>
<h1><span lang=EN-US>Hyponatraemia and hypernatraemia</span></h1>
<h2><i><span lang=EN-US>Executive summary</span></i></h2>
<h2><span lang=EN-US>Introduction</span></h2>
<p class=MsoNormal><span lang=EN-US>Abnormalities in serum sodium are
relatively common in our admitted population – especially in those with
hypertension, heart failure or liver disease. An abnormal sodium level has been
shown to be associated with poor outcome following hospital admission. It is
very important that these abnormalities are noticed and responded to as soon as
possible. </span></p>
<p class=MsoNormal><span lang=EN-US>Remember that abnormalities can result from
laboratory errors or other factors around specimen collection and storage. It
is very important to relate any abnormal results to the clinical state of the
patient and to repeat the laboratory test whenever there is any uncertainty. </span></p>
<p class=MsoNormal><span lang=EN-US>Note: </span></p>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
36.0pt'><span lang=EN-US>TBW (men) = 0.6 L/kg × weight in kg </span></p>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;text-indent:
36.0pt'><span lang=EN-US>TBW (women) = 0.5 L/kg × weight in kg</span></p>
<h2><span lang=EN-US>Target users</span></h2>
<p class=MsoListParagraphCxSpFirst style='margin-left:39.0pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Doctors</span></p>
<p class=MsoListParagraphCxSpLast style='margin-left:39.0pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Nurses</span></p>
<h2><span lang=EN-US>Target area of use </span></h2>
<p class=MsoListParagraphCxSpFirst style='margin-left:39.0pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Outpatient department</span></p>
<p class=MsoListParagraphCxSpLast style='margin-left:39.0pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Ward</span></p>
<h2><span lang=EN-US>Key areas of focus / New additions / Changes </span></h2>
<p class=MsoNormal><span lang=EN-US>This guideline describes the correction of
abnormal sodium results. </span></p>
<p class=MsoNormal><span lang=EN-US>Note that great care should be taken in
correcting the sodium level in malnourished children. Commonly, these children
have raised total body sodium even if the serum sodium level is reduced. Usually
the blood results will improve as the nutrition status improves. </span></p>
<p class=MsoNormal><span lang=EN-US>Rapid shifts in serum sodium are associated
with irreversible brain injury so correction must be undertaken cautiously.</span></p>
<h2><span lang=EN-US>Limitations</span></h2>
<p class=MsoNormal><span lang=EN-US>We do not keep hypertonic or hypotonic
sodium solutions.</span></p>
<span lang=EN-US style='font-size:11.0pt;font-family:"Arial","sans-serif"'><br
clear=all style='page-break-before:always'>
</span>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
lang=EN-US style='font-size:12.0pt'>&nbsp;</span></b></p>
<h1><a name="_Hlk534367223"><span lang=EN-US>Hyponatraemia</span></a></h1>
<p class=MsoNormal><span lang=EN-US>This is defined as Na &lt; 135 mmol/L. It
is severe if ≤ 120 mmol/L. </span></p>
<h2><span lang=EN-US>Causes</span></h2>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Isotonic hyponatraemia: hyperlipidemia or
proteinaemia</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Hypertonic hyponatraemia: glucose or mannitol
infusion.</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Euvolemic hyponatraemia: syndrome of
inappropriate ADH (SIADH) secretion, hypothyroidism, adrenal insufficiency and medications
such as thiazide diuretics, NSAIDs and SSRIs </span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Hypovolemic: haemorrhage, vomiting, diarrhoea,
burns</span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span lang=EN-US
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Hypervolemic: congestive heart failure, liver
cirrhosis.</span></p>
<h2><span lang=EN-US>Presenting symptoms and signs</span></h2>
<p class=MsoNormal><span lang=EN-US>Symptoms and signs are usually obvious in
patients who have sudden onset of hyponatraemia or have severe hyponatraemia
and they include :</span></p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Headache </span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Lethargy</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Nausea</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Depressed reflexes </span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Disorientation </span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Seizures  </span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span lang=EN-US
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Coma</span></p>
<p class=MsoNormal><span lang=EN-US>Other symptoms and signs are dependent on
the volume status of the patient:</span></p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Dizziness, postural hypotension and syncope –
hypovolaemia </span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span lang=EN-US
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Peripheral oedema, pleural effusion or ascites –
hypervolaemia</span></p>
<h2><span lang=EN-US>Management</span></h2>
<p class=MsoNormal><span lang=EN-US>Medications such as diuretics should be
reviewed or stopped if they are thought to be responsible for hyponatraemia. </span></p>
<p class=MsoNormal><span lang=EN-US>The causes of hyperlipidaemia and
hyperproteinaemia should be found and treated.</span></p>
<p class=MsoNormal><span lang=EN-US>Endocrinologic disorders should be managed
accordingly. SIADH is managed with fluid restriction at first and then diuresis
if there is no improvement.  </span></p>
<p class=MsoNormal><span lang=EN-US>The treatment of hypervolemic hyponatraemia
is with diuresis - preferably loop diuretics.</span></p>
<h3><span lang=EN-US>Correction</span></h3>
<p class=MsoListParagraph style='text-indent:-18.0pt'><span lang=EN-US
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Na deficit (mmol/L) = Total Body Water (TBW) × (140
– measured serum Na concentration)</span></p>
<p class=MsoNormal><span lang=EN-US>Normal saline is used for correction of
hyponatremia in our setting and this can be calculated using the following
formula:</span></p>
<p class=MsoListParagraphCxSpFirst style='margin-bottom:0cm;margin-bottom:.0001pt;
text-indent:-18.0pt'><span lang=EN-US style='font-family:Symbol'>·<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Change in serum Na = Infusate Na – Serum Na /
(total body water +1) </span></p>
<p class=MsoListParagraphCxSpLast style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-US>&nbsp;</span></p>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-US>This gives the change in serum sodium per litre of infusate. Note: Infusate
Na is 154 mmol/L for 0.9% saline intravenous infusion.</span></p>
<p class=MsoListParagraph style='margin-left:0cm'><span lang=EN-US>Use the
calculator on this website to determine the infusion rate: <a
href="https://www.mdcalc.com/sodium-correction-rate-hyponatremia-hypernatremia">https://www.mdcalc.com/sodium-correction-rate-hyponatremia-hypernatremia</a>
</span></p>
<p class=MsoNormal><span lang=EN-US>Correction should be done at a rate of 1-2
mmol/L/hour (in acute conditions) or 0.5 mmol/L/hour (in chronic conditions)
over 40 hours. Fifty percent of the fluid should be given in the 1st 24 hrs and
not exceeding 12 mmol/24hrs. This is to prevent cerebral pontine myelinolysis</span></p>
<p class=MsoNormal><span lang=EN-US>Monitoring of serum Na should be done after
every 4-6 hours.</span></p>
<h1><span lang=EN-US>Hypernatraemia</span></h1>
<p class=MsoNormal><span lang=EN-US>This is defined as Na &gt; 145 mmol/L. It
is severe if ≥ 160 mmol/L.</span></p>
<h2><span lang=EN-US>Causes </span></h2>
<div class="tableCont">
  <table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=141 valign=top style='width:106.1pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US>Type of fluid loss or gain </span></b></p>
  </td>
  <td width=434 valign=top style='width:325.4pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span lang=EN-US>Causes </span></b></p>
  </td>
 </tr>
 <tr>
  <td width=141 valign=top style='width:106.1pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Net water loss</span></p>
  </td>
  <td width=434 valign=top style='width:325.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Unreplaced insensible loss (dermal and
  respiratory)</span></p>
  <p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Inadequate fluid intake/impaired thirst –
  typically in elderly people</span></p>
  <p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Diabetes insipidus</span></p>
  </td>
 </tr>
 <tr>
  <td width=141 valign=top style='width:106.1pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Hypotonic fluid loss</span></p>
  </td>
  <td width=434 valign=top style='width:325.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Renal causes, e.g. osmotic diuresis in
  uncontrolled diabetes</span></p>
  <p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Medicines, e.g. loop diuretics, mannitol,
  urea, corticosteroids (increase production of urea), high protein supplements</span></p>
  <p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Gastrointestinal losses, e.g. diarrhoea,
  vomiting, fistulae, use of osmotic laxatives (lactulose, sorbitol)</span></p>
  <p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Cutaneous loss, e.g. burns, excessive sweating</span></p>
  </td>
 </tr>
 <tr>
  <td width=141 valign=top style='width:106.1pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span lang=EN-US>Hypertonic fluid gain</span></p>
  </td>
  <td width=434 valign=top style='width:325.4pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>Ingestion of salt, salt water, sodium rich
  enemas</span></p>
  <p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span
  lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </span></span><span lang=EN-US>IV hypertonic infusions, e.g. sodium
  bicarbonate, sodium chloride</span></p>
  </td>
 </tr>
</table>
</div>
<p class=MsoNormal><b><span lang=EN-US>&nbsp;</span></b></p>
<h2><span lang=EN-US>Presenting symptoms and signs </span></h2>
<p class=MsoNormal><span lang=EN-US>These become obvious as the hypernatraemia
becomes more severe:</span></p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Thirst</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Fever </span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Sensorium change</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Seizure </span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Focal neurological deficits</span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span lang=EN-US
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Hyperventilation</span></p>
<span lang=EN-US style='font-size:11.0pt;font-family:"Arial","sans-serif"'><br
clear=all style='page-break-before:always'>
</span>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
lang=EN-US style='font-size:12.0pt'>&nbsp;</span></b></p>
<h2><span lang=EN-US>Management</span></h2>
<p class=MsoNormal><span lang=EN-US>Stop or decrease dosage of medications and
infusions which are likely causes of hypernatremia.</span></p>
<h3><span lang=EN-US>Adults</span></h3>
<p class=MsoNormal><b><span lang=EN-US>Mild to moderate hypernatraemia</span></b><span
lang=EN-US> (Na 146-159 mmol/l): oral water therapy may be sufficient. </span></p>
<p class=MsoNormal><b><span lang=EN-US>Severe hypernatraemia</span></b><span
lang=EN-US> (Na &gt; 160 mmol/l): use IV 5% Dextrose with the aim to reduce Na
at a rate of 0.5 mmol/hr and not more than 10 mmol/24hrs. Monitor Na every 4
hours. Note that too rapid a correction of the Na can cause cerebral oedema,
convulsions and brain injury. </span></p>
<h3><span lang=EN-US>Children</span></h3>
<p class=MsoNormal><b><span lang=EN-US>Mild hypernatraemia </span></b><span
lang=EN-US>(Na 146-149 mmol/l): enourage drinking. Stop any feed fortifications
(eg extra scoops of formula – not F75 or F100).</span></p>
<p class=MsoNormal><b><span lang=EN-US>Moderate hypernatraemia </span></b><span
lang=EN-US>(Na 150-169 mmol/l):</span></p>
<p class=MsoNormal style='margin-bottom:3.75pt;background:white'><span
lang=EN-US>If &quot;shocked&quot;, resuscitate with boluses 20ml/kg of 0.9%
saline as required.</span></p>
<p class=MsoNormal><span lang=EN-US>After initial resuscitation, replace the
deficit plus maintenance slowly at a uniform rate </span><span lang=EN-US><a
href="https://www.rch.org.au/clinicalguide/guideline_index/Hypernatraemia/#1"
title="over 48 hours"><span style='color:windowtext'>over 48 hours</span></a></span><b><span
lang=EN-US>.</span></b><span lang=EN-US> </span></p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Nasogastric rehydration is preferred</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-US>Carefully regulate fluid intake - do not allow
excessive intake in a thirsty child.</span></p>
<p class=MsoListParagraphCxSpMiddle style='margin-left:72.0pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-US>If the serum sodium falls too rapidly (&gt; 0.5
mmol/l/hr) slow the rate of rehydration (for example, by 20%) or change to
intravenous fluids. </span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>If needing intravenous rehydration use <b>0.9%
sodium chloride (normal saline) and 5% Glucose</b>. Add maintenance KCl once urine
output established. </span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Check U&amp;Es and glucose frequently intially. </span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>If after 6 hours of rehydration therapy, the
sodium is decreasing at a steady rate then check the U&amp;Es and glucose 4
hourly.</span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span lang=EN-US
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>If serum sodium is falling faster than 1 mmol/l/hr,
stop infusate and seek senior support.</span></p>
<p class=MsoNormal><b><span lang=EN-US>Severe hypernatraemia </span></b><span
lang=EN-US>(Na &gt; 170 mmol/l):</span></p>
<p class=MsoNormal><span lang=EN-US>This is a medical emergency. </span><span
lang=EN-US>After initial resuscitation, aim to replace deficit and maintenance
with<b> 0.9% sodium chloride (normal saline) and 5% glucose</b> over 72 - 96
hours. Seek senior support early and monitor U&amp;Es up to hourly. Involve lab
staff as soon as possible.</span></p>
<h3><span lang=EN-US>Calculation</span></h3>
<p class=MsoListParagraph style='text-indent:-18.0pt'><span lang=EN-US
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Water deficit (in litres) = TBW × ([Na/140] – 1 </span></p>
<p class=MsoNormal><span lang=EN-US>This determines the amount of fluid to be
infused over 48 hours. </span></p>
<p class=MsoListParagraph style='text-indent:-18.0pt'><span lang=EN-US
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Change in Na = Infusate Na – Na / (total body
water +1) </span></p>
<p class=MsoNormal><span lang=EN-US>This gives the change in Na per litre of
infusate. If using 5% dextrose the infusate Na is 0.</span></p>
<p class=MsoNormal><span lang=EN-US>You may use the calculator on this website
to determine the rate of fluid infusion : <a
href="https://www.mdcalc.com/sodium-correction-rate-hyponatremia-hypernatremia">https://www.mdcalc.com/sodium-correction-rate-hyponatremia-hypernatremia</a>
</span></p>
<h2><span lang=EN-US>Key Issues for Nursing care</span></h2>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
lang=EN-US style='font-size:12.0pt;font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Severe hyponatraemia and hypernatraemia can both
have serious long term consequences. These can be worsened if the correction is
too rapid.</span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Follow the fluid instructions very carefully. </span></p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Make sure repeat tests are done on time and are
reviewed by a doctor promptly. </span></p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span lang=EN-US
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>All patients with abnormal Na levels should have
strict monitoring of fluid input and output.</span></p>
<h2><span lang=EN-US>References</span></h2>
<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>Bartel B, Gau E.
Fluid and Electrolyte Management. Critical Care Pharmacotherapeutics.
Burlington, MA: Jones &amp; Bartlett Learning. 2012 Feb 8:125-50.</span></p>
<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>Hoorn EJ, Tuut MK,
Hoorntje SJ, van Saase JL, Zietse R, Geers AB. Dutch guideline for the
management of electrolyte disorders-2012 revision. Neth J Med. 2013 Apr
1;71(3):153-65.</span></p>
<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>Kraft MD, Btaiche
IF, Sacks GS, Kudsk KA. Treatment of electrolyte disorders in adult patients in
the intensive care unit. American Journal of Health-System Pharmacy. 2005 Aug
15;62(16):1663-82.</span></p>
<div class="tableCont">
  <table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr style='height:1.0pt'>
  <td width=143 valign=top style='width:106.95pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>Written by:</span></b></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Orighomisan Agboghoroma</span></p>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Mariama Sonko</span></p>
  </td>
  <td width=191 valign=top style='width:143.45pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Date: 07 January 2019</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>Reviewed by:</span></b></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Karen Forrest</span></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Date: 08 May 2019</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>Version:</span></b></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>Change history:</span></b></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>Review due date:</span></b></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>1.0</span></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>New document</span></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>31 May 2021</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Review Comments (<i>if applicable)</i></span></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>&nbsp;</span></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>&nbsp;</span></b></p>
  </td>
 </tr>
</table>
</div>
<p class=MsoNormal><span style='color:black'>&nbsp;</span></p>
</div>
</div><!-- /content -->

</div>

</body>
</html>
